RiboTargets Ltd ( Visit this link)
Vernalis is a new force in UK biotechnology formed out of the September 2003 merger of British Biotech plc and Vernalis Group plc. This merger has created a company with significant growth potential, through sales of its marketed product, frovatriptan, the successful development and commercialisation of its product pipeline candidates, and through further participation in the consolidation of the UK biotechnology sector. Research and development of therapeutics to treat patients with bacterial infections and patients with cancer.
Site Preview
Alexa Traffic Graph
Reviews
No reviews.